Mahdi Nalini, M.D., Ph.D., joined the Metabolic Epidemiology Branch (MEB) as a postdoctoral fellow in January 2023. He earned an M.D. from Kermanshah University of Medical Science, Iran, in 1997. Dr. Nalini worked as a physician in the first cardiac rehabilitation center in the west of Iran, which was established by his team in 2000. He earned his Ph.D. in clinical sciences from Tehran University of Medical Sciences in 2019. Working with Professor Reza Malekzadeh and Professor Farin Kamangar, his Ph.D. research focused on the roles of obesity, opium, and polypill in cardiovascular diseases.
In MEB, Dr. Nalini’s research interests include the prevention of premature mortality through the control of risk factors. He is working under the mentorship of Arash Etemadi, M.D., Ph.D., staff scientist, and Christian C. Abnet, Ph.D., M.P.H., Director of MEB and senior investigator, to study metabolomics and exposure biomarkers in cancer and other chronic diseases, within collaborations between NCI and the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention, and the International Hundred K+ Cohort Consortium.